European Union Meeting Performance Goals For New Drug Review, But Lags Behind U.S. In New Drug Availability, According To Tufts Center for the Study of Drug Development

BOSTON, MA -- (MARKET WIRE) -- January 16, 2007 -- Review times for new drugs in the European Union have met mandated performance goals, but many medicines are available in the United States prior to the EU, according to a study recently completed by the Tufts Center for the Study of Drug Development.